InvestorsHub Logo
Followers 3
Posts 155
Boards Moderated 0
Alias Born 09/24/2018

Re: None

Wednesday, 03/27/2019 6:32:30 AM

Wednesday, March 27, 2019 6:32:30 AM

Post# of 425648
PCP Knowledge
Yesterday morning my mother told me her PCP was “pushing” for her to start Vascepa. She is reluctant due to the price being $375/month. She is not in a position to add this cost to her budget and doesn’t have particularly high trigs or cholesterol though I’m not sure the exact numbers. She is 75.

In the afternoon I had my annual physical. I’m on generic Crestor and have been for years. When reviewing my lipid panel my trigs were 95 and total cholesterol was 165. I mentioned Vascepa to my Dr. She was aware of it and the trials but said she had never prescribed it. She prescribed it to me with very little prodding. I think she wanted to see it in action. I’ll find out this afternoon the cost when my wife goes to pick up the prescription.

I’m in Raleigh NC and my mom is in Pittsburgh. Both PCPs well aware of Vascepa and willing to prescribe. This leads me to think the real missing ingredient is insurance coverage not physician knowledge of the product. I believe the big sales and pps increase we all are waiting for is dependent purely on insurance coverage IMO. The cost/benefit study from the company showing the decrease in overall costs from fewer MACE can’t come soon enough.

As far as maximizing my investment I believe the company staying independent while it increases coverage and enjoys the exponential increase in sales and share price that is likely to come during that time would be preferable. After that selling to big pharma at a nice premium would be fine. I don’t want the exponential part of the curve being owned by big pharma though it would make me lots of money.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News